Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized placebo-controlled phase 2 trial of probiotic AH1206 in irritable bowel syndrome
2009-015728-27Phase 2Completed
- Sponsor
- Alimentary Health Ltd.
- Start
- Sep 2009
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing AH1206 probiotic with Placebo (2 arms). Primary endpoint: Global Improvement in IBS symptoms. Started Sep 2009; status: completed.
02
Drugs
AH1206
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2009-015728-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015728-27.